Value of Doppler-echo for the prognosis and follow up of hypertrophic cardiomyopathy;Valor del ecocardiograma-Doppler en el pronóstico y en el seguimiento de la miocardiopatía hipertrófica

Revista Espanola de Cardiologia

Volumn 54, Issue 1, 2001, Pages 7-15

  Candell Riera, Jaume ^a   Romero Farina, Guillermo ^a   Galve Basilio, Enrique ^a   Palet Balart, Jordi ^a   Armadans, Lluís ^a   Reina, Ma Dolores ^a   García Del Castillo, Herminio ^a   Soler Soler, Jordi ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Cardiomyopathy; Echocardiography; Prognosis

Indexed keywords

ARTICLE; DOPPLER ECHOCARDIOGRAPHY; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; MIDDLE AGED; PROGNOSIS;

CARDIOMYOPATHY, HYPERTROPHIC; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS;

EID: 0035219932     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0300-8932(01)76258-6     Document Type: Article

References (58)

1. Spirito P, Seidman CE, McKenna WJ, Maron BJ. Management of hypertrophic cardiomyopathy. N Engl J Med 1997; 336: 775-785.
2. Wigle ED, Rakowski H, Kimball BP, Williams WG. Hypertrophic cardiomyopathy: clinical spectrum and treatment. Circulation 1995; 92: 1680-1692.
3. Maron BJ. Hypertrophic cardiomyopathy. Lancet 1997; 350: 127-133.
4. Maron BJ, Moller JH, Seideman CE. Impact of laboratory molecular diagnosis on contemporary diagnostic criteria for genetically transmitted cardiovascular diseases: hypertrophic cardiomyopathy, long-QT syndrome and Marfan syndrome. Circulation 1998; 98: 1460-1471.
5. Wigle ED, Sasson Z, Henderson MA, Ruddy TD, Fulop J. Rakowski H et al. Hypertrophic cardiomyopathy. The importance of the site and extent of hypertrophy. A review. Prog Cardiovasc Dis 1985; 28: 1-83.
6. Maron BJ, Bonow RO, Cannon RO III, Leon BJ, Epstein SE. Hypertrophic cardiomyopathy: interrelation of clinical manifestations, pathophysiology, and therapy. N Engl J Med 1987; 316: 780-789.
7. Louie EK, Edwards LC. Hypertrophic cardiomyopathy. Prog Cardiovasc Dis 1994; 36: 275-308.
8. Hecht GM, Klues HG, Roberts WC, Maron BJ. Coexistence of sudden cardiac death end-stage heart failure in familial hypertrophic cardiomyopathy. J Am Coll Cardiol 1993; 22: 489-497.
9. Webb JG, Sasson Z, Rakowski H, Liu P, Wigle ED. Apical hypertrophic cardiomyopathy: clinical follow-up and diagnostic correlates. J Am Coll Cardiol 1990; 15: 83-90.
10. Spirito P, Maron BJ, Bonow RO, Epstein SE. Ocurrence and significance of progressive left ventricular wall thinning and relative cavity dilatation in patients with hypertrophic cardiomyopathy. Am J Cardiol 1987; 60: 123-129.
11. Maron BJ, Spirito P, Wesley Y, Arce J. Development and progression of left ventricular hypertrophy in children with hypertrophic cardiomyopathy. N Engl J Med 1986; 315: 610-614.
12. Domenicucci S, Lazzeroni E, Roelandt J, Ten Cate FJ, Vletter WB, Arntzenius AC. Progression of hypertrophic cardiomyopathy. A cross sectional echocardiographic study. Br Heart J 1985; 53: 405-411.
13. Maron BJ, Spirito P. Implications of left ventricular remodeling in hypertrophic cardiomyopathy. Am J Cardiol 1998; 81: 1339-1344.
14. Yutani Ch, Imakita M, Ishibashi-Ueda H, Hatanaka K, Nagata S, Sakakibara H et al. Three autopsy cases of progression to left ventricular dilatation in patients with hypertrophic cardiomyopathy. Am Heart J 1985; 109: 545-548.
15. Ten Cate FJ, Roelandt J. Progression to left ventricular dilatation in patients with hypertrophic obstructive cardiomyopathy. Am Heart J 1979; 97: 762-765.
16. Beder SD, Gutgesell HP, Mullins ChE, McNamara DG. Progression from hypertrophic obstructive cardiomyopathy to congestive cardiomyopathy in a child. Am Heart J 1982; 104: 155-156.
17. Fighali S, Krajcer Z, Edelman S, Leachman RD. Progression of hypertrophic cardiomyopathy into a hypokinetic left ventricle: Higher incidence in patients with midventricular obstruction. J Am Coll Cardiol 1987; 9: 288-294.
18. Ciró E, Maron BJ, Bonow RO, Cannon R, Epstein S. Relation between marked changes in left ventricular outflow tract gradient and disease progression in hypertrophic cardiomyopathy. Am J Cardiol 1984; 53: 1103-1109.
19. Kizilbash AM, Heinle SK, Grayburn PA. Spontaneous variability of left ventricular outflow tract gradient in hypertrophic obstructive cardiomyopathy. Circulation 1998; 97: 461-466.
20. Horimoto M, Yokota K, Inoue H, Takenaka T, Doi H, Ohno T et al. Development of obstructive hypertrophic cardiomyopathy from nonobstructive hypertrophie cardiomyopathy. Am J Cardiol 1998; 82: 403-405.
21. Panza JA, Maris TJ, Maron BJ. Development and determinants of dynamic obstruction to left ventricular outflow in young patients with hypertrophic cardiomyopathy. Circulation 1992; 85: 1398-1405.
22. Spirito P, Bellone P. Natural history of hypertrophic cardiomyopathy. Br Heart J 1994; 72: S10-S12.
23. Spirito P, Maron BJ. Absence of progression of left ventricular hypertrophy in adult patients with hypertrophic cardiomyopathy. Am J Cardiol 1987; 9: 1013-1017.
24. Spirito P, Maron BJ. Relation between extent of left ventricular hypertrophy and occurrence of sudden cardiac death in hypertrophic cardiomyopathy. Circulation 1990; 15: 1521-1526.
25. McKenna WJ, Montserrat-Iglesias L. Identificación y tratamiento de los pacientes con miocardiopatía hipertrófica y riesgo de muerte súbita. Rev Esp Cardiol 2000; 53: 123-130.
26. Galve-Basilio E, Alfonso-Manterola F, Ballester-Rodés M, Castro-Beiras A, Fernández de Soria-Pantoja R, Penas-Lado M et al. Guías de práctica clínica de la Sociedad Española de cardiología en miocardiopatías y miocarditis. Rev Esp Cardiol 2000; 53: 360-393.
27. Spirito P, Bellone P, Harris KM, Bernabo P, Bruzzi P, Maron BJ. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med 2000; 342: 1778-1785.
28. Maron BJ, Gottdiener JS, Epstein SE. Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. A wide-angle, two-dimensional echocardiographic study of 125 patients. Am J Cardiol 1981; 48: 418-428.
29. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 6: 1072-1083.
30. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation 1977; 55: 613-681.
31. Van Dam I, Fast J, De Boo T, Hopman J, Van Oort A, Heringa A, et al. Normal diastolic filling patterns of the left ventricle. Eur Heart J 1988; 9: 165-171.
32. Helmeke F, Nanda NC, Hsiung MC, Soto B, Adey CK, Goyal RG, et al. Color Doppler assessment of mitral regurgitation with ortogonal planes. Circulation 1987; 75: 175-183.
33. Candell-Riera J, Álvarez-Auñón A, Balda-Caravedo F, García del Castillo H. Clasificación morfológica de la miocardiopatía hipertrófica mediante ecocardiograma bidimensional. Rev Esp Cardiol 1986; 39: 358-363.
34. Koga Y, Itaya K, Toshima H. Prognosis in hypertrophic cardiomyopathy. Am Heart J 1984; 108: 351-359.
35. Kofflard MJ, Waldstein DJ, Vos J, Ten Cate FJ. Prognosis in hypertrophic cardiomyopathy observed in a large clinic population. Am J Cardiol 1993; 72: 939-943.
36. Cecchi F, Olivotto I, Montereggi A, Santoro G, Dolara A, Maron BJ. Hypertrophic cardiomyopathy in Tuscany: Clinical course and outcome in an unselected regional population. J Am Coll Cardiol 1995; 26: 1529-1536.
37. Maki S, Ikeda H, Muro A, Yoshida N, Shibata A, Koga Y et al. Predictors of sudden cardiac death in hypertrophic cardiomyopathy. Am J Cardiol 1998; 82: 774-778.
38. Kyriakidis M, Triposkiadis F, Anastasakis A, Thepistou A, Tocta R, Barbetseas J et al. Prognosis of completely asymptomatic adult patients with hypertrophic cardiomyopathy. Chest 1998; 114: 1091-1096.
39. Takagi E, Yamakado T, Nakano T. Prognosis of completely asymptomatic adult patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1999; 33: 206-211.
40. Maron BJ, Casey SA, Poliac LC, Gohman TE, Almquist AK. Aeppli DM. Clinical course of hypertrophic cardiomyopathy in a regional United States cohort. JAMA 1999; 281: 650-655.
41. Álvarez-Auñón A, Candell-Riera J, Balda-Caravedo F, García del Castillo H, Soler-Soler J. ¿Existen diferencias ecocardiográficas entre los pacientes sintomáticos y asintomáticos afectos de miocardiopatía hipertrófica? Rev Esp Cardiol 1988; 41: 143-147.
42. McKenna WJ, Borggrefe M, England D, Deanfield J, Oakley CM, Goodwin JF. The natural history of left ventricular hypertrophy in hypertrophic cardiomyopathy: an electrocardiographic study. Circulation 1982; 66: 1233-1240.
43. Steward S, Mason DT, Braunwald E. Impaired rate of left ventricular filling in idiopathic hypertrophic subaortic stenosis and valvular aortic stenosis. Circulation 1968; 37: 8-14.
44. Goodwin JF. Congestive and hypertrophic cardiomyopathies. A decade of study. Lancet 1970; 1: 731-739.
45. Sanderson JE, Gibson DG, Brown DJ, Goodwin JF. Left ventricular filling in hypertrophic cardiomyopathy: an angiographic study. Br Heart J 1977; 39: 661-670.
46. Bonow RO, Rosing DR, Bacharach SL, Green MV, Kent KM, Lipson LC et al. Effects of verapamil on left ventricular systolic function and diastolic filling in patients with hypertrophic cardiomyopathy. Circulation 1981; 64: 787-796.
47. Lorell BH, Paulus WJ, Grossman W, Wynne J, Cohn PF. Modification of abnormal left ventricular diastolic properties by nifedipine in patients with hypertrophic cardiomyopathy. Circulation 1982; 65: 499-507.
48. Maron BJ, Epstein SE, Roberts WC. Hypertrophic cardiomyopathy and transmural myocardial infarction without significant atherosclerosis of the extramural coranary arteries. Am J Cardiol 1979; 43: 1086-1102.
49. Waller BF, Maron BJ, Epstein SE, Roberts WC. Transmural myocardial infarction in hypertrophic cardiomyopathy: a cause of conversion from left ventricular asymmetry to symmetry and from normal sized to dilated left ventricular cavity. Chest 1981; 79: 461-465.
50. Frank S, Braunwald E. Idiopathic hypertrophic subaortic stenosis: clinical analysis of 126 patients with emphasis on the natural history. Circulation 1968; 35: 759-770.
51. Adelman AG, Wigle ED, Ranganathan N, Webb GD, Kidd BSL, Bigelow WG et al. The clinical course in muscular subaortic stenosis. Ann Intern Med 1972; 77: 515-518.
52. Shah PM, Sylvester LJ. Echocardiography in the diagnosis of hypertrophic obstructive cardiomyopathy. Am J Med 1977; 62: 830-835.
53. Carter WH, Whalen RE, McIntosh HD. Reversal of hemodynamic and phonocardiographic abnormalities in idiopathic hypertrophic subaortic stenosis. Am J Cardiol 1971; 28: 722-727.
54. Sagie A, Benjamin EJ, Galderisi M, Larson MG, Evans JC, Fuller DL et al. Reference values for Doppler indexes of left ventricular diastolic filling in the elderly. J An Soc Echocardiogr 1993; 6: 570-576.
55. Nishimura RA, Appleton ChA, Redfield MM, Ilstrup DM, Holmes DR, Tajik J. Noninvasive Doppler-echocardiographic evaluation of left ventricular filling pressures in patients with cardiomyopathies: a simultaneous Doppler-echocardiographic and cardiac catheterization study. J Am Coll Cardiol 1996: 28: 1226-1233.
56. Pavin D, De Place C, Le Breton H, Leclercq C, Gras D, Victor F et al. Effects of permanent dual-chamber pacing on mitral regurgitation in hypertrophic obstructive cardiomyopaty. Eur Heart J 1999; 20: 203-210.
57. Wallerson DC, Defereux RB. Reoroducibility of quantitative echocardiogiaphy: factors affecting variability of imaging and Doppler measurements. Echocardiography 1986; 3: 219-235.
58. Clark RD, Korcuska K, Cohn K. Serial echocardiographic evaluation of left ventricular function in valvular disease, including reproducibility guidelines for serial studies. Circulation 1980; 62: 564-570.